Loading Events

Surgical Treatment of TN: What to Choose and When

FPA webinars are FREE and open to everyone affected by facial pain.

When medical therapies are not working for a person with TN, there are several effective surgical options. Choosing between the different options can be confusing. During this webinar, Dr. Lim will discuss the pros and cons of the various surgical options for treating TN.

Dr. Lim is the Chair of the Department of Neurosurgery and a board-certified neurosurgeon specializing in brain tumors and trigeminal neuralgia. Dr. Lim’s clinical interests include the treatment of benign and malignant brain tumors, with special interest in gliomas, meningiomas, metastatic tumors, and skull base tumors. Dr. Lim also specializes in surgical treatments for trigeminal neuralgia.

NOTE: For security purposes, webinars hosted by the Facial Pain Association will require that participants be authenticated to join. This means that participants will need to have a Zoom account and will need to sign in to their Zoom account before they can join the webinar. If you do not have a Zoom account, you can sign up for one for free at https://www.zoom.us/signup

A recording of the webinar will be available the following week on our website at https://www.facepain.org/tag/webinars/ and on our YouTube Channel at https://www.youtube.com/c/FacialPainAssociation

Share on facebook
Share on email
Share on twitter

Subscribe

Signup for relevant content in your inbox.

Learn

View or Download the Patient Guide

Learn more about neuropathic facial pain, including how to get a diagnosis, treatments, and more by viewing or downloading our free patient guide.

By filling out the form below, you will receive a free FPA Patient Guide and periodic updates on the management and treatment of facial pain conditions. We do not share this information with any outside sources.

By filling out the form below, you will receive a free FPA Patient Guide and periodic updates on the management and treatment of facial pain conditions. We do not share this information with any outside sources.